September 23, 2022
2 min learn
The College of Michigan Nationwide Ballot on Wholesome Getting older revealed that 70% of individuals aged 50 years or older expertise joint ache to some extent. Amongst them, two-thirds mentioned they use over-the-counter therapies to handle the ache.
In accordance with Beth Wallace, MD, MS, a rheumatologist on the VA Ann Arbor Well being Care System, many of those sufferers are receiving insufficient therapy info from their well being care suppliers.
“Sixty p.c of these taking two or extra substances for his or her joint ache mentioned their well being care supplier hadn’t talked with them about dangers, or they couldn’t recall if that they had,” mentioned Wallace in a press launch asserting the ballot’s outcomes. It was the highest story in rheumatology final week.
One other prime story coated the newly launched Honest Entry in Residency Act. The bipartisan invoice seeks to make sure equitable entry for DO and MD residency candidates to graduate medical teaching programs. The American Affiliation of Schools of Osteopathic Drugs mentioned in a press launch that the invoice would deal with “the unfair limitations and discrimination that osteopathic medical college students face when making use of to federally funded residency coaching.”
Learn these and extra prime tales in rheumatology under:
Two-thirds of older adults with joint ache use OTC therapies to handle ache
Most older adults with joint ache really feel they’ll handle mentioned ache with out doctor help, whereas 66% report they deal with their joint ache with over-the-counter medicine comparable to acetaminophen or ibuprofen, in accordance with a ballot. Read more.
Bipartisan invoice would require residency applications to equitably assess DO, MD candidates
A newly launched invoice within the U.S. Home of Representatives would require federally funded graduate medical teaching programs to equitably assess and settle for each DO and MD residency candidates, in accordance with a press launch. Read more.
FDA grants fast-track designation for efzofitimod in systemic sclerosis-associated ILD
The FDA has granted fast-track designation for efzofitimod (ATYR1923, aTyr), a possible first-in-class immunomodulator, within the therapy of systemic sclerosis-associated interstitial lung illness, in accordance with a press launch from the drug’s producer. Read more.
VIDEO: ACR criticizes Medicare contractors for ‘inappropriately low reimbursement’
Medicare administrative contractors are circumventing the conventional coverage course of associated to advanced drug administration codes, resulting in “inappropriately low reimbursement,” in accordance with the American Faculty of Rheumatology. Watch video.
ACR: Sufferers on long-term glucocorticoids ought to obtain oral bisphosphonates
Sufferers receiving long-term glucocorticoids ought to use oral bisphosphonates to cut back the danger for bone loss and fracture, in accordance with new tips at present underneath peer evaluate from the American Faculty of Rheumatology. Read more.